Horizon Pharma plc Announces Multiple Data Presentations Highlighting the Growing Burden of Uncontrolled Gout at ...
(World News Science)

DUBLIN--(BUSINESS WIRE)--Horizon Pharma plc (Nasdaq: HZNP) today announced that multiple studies demonstrating the extensive burden of uncontrolled gout and its impact on patients will be presented at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting, Oct. 19-24, in Chicago. In addition to the data presentations, Horizon will host an academic lecture facilitated by prominent researchers on scientific advancements in the understa ......